Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DNASE1L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC100505853 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC00924 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD53 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZSWIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POU2F2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPP14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WNK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMPDL3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGB2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01535 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENTPD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on